About Trilogene Seeds

Trilogene Seeds, founded in 2018 by CEO Matthew Haddad, is a prominent cannabis genetics company headquartered in Longmont, Colorado. Specializing in the development and stabilization of elite American cannabis strains, the company offers a diverse range of feminized hemp seeds tailored for various applications, including efficient extraction processes, tri-crop cultivation, and premium smokable products. Their commitment to leveraging cutting-edge technology ensures the creation of stable genetics adaptable to diverse microclimates and photoperiods worldwide.

Global Collaborations and Market Expansion

Recognizing the importance of global partnerships, Trilogene Seeds has collaborated with international entities to expand the reach of their innovative genetics. A notable partnership with Puro, a medicinal cannabis producer in New Zealand, marks a significant milestone as Puro becomes the first to cultivate triploid cannabis in the Southern Hemisphere. This collaboration underscores Trilogene Seeds' commitment to promoting sustainable and ethical cannabis production on a global scale.

Through continuous innovation, rigorous scientific research, and strategic global partnerships, Trilogene Seeds has established itself as a leader in the cannabis genetics industry, dedicated to advancing cultivation practices and delivering superior products to the market.

Trilogene Seeds has been at the forefront of pioneering advancements in cannabis breeding, notably through the introduction of triploid cannabis seeds. Triploid plants possess three sets of chromosomes, rendering them effectively sterile. This sterility eliminates the risk of pollination, ensuring consistent, seedless harvests with enhanced cannabinoid profiles. The adoption of triploid genetics, a concept successfully applied in other agricultural sectors like seedless watermelons, offers significant benefits for both indoor and outdoor cultivators by promoting uniform growth and reducing cultivation risks associated with unwanted pollination.

In addition to triploid innovations, Trilogene Seeds has developed the “THC Null” trait, a groundbreaking hemp cultivar engineered to prevent the production of tetrahydrocannabinol (THC). Utilizing RNA interference (RNAi) technology, this trait silences the genetic pathways responsible for THC synthesis, enabling farmers to cultivate hemp without the concern of exceeding legal THC thresholds. This advancement not only aids in regulatory compliance but also enhances extraction efficiencies for cannabidiol (CBD) and other non-psychoactive cannabinoids.

Trilogene Seeds offers an extensive selection of cannabis seeds, including autoflowering and feminized varieties. Their catalog features strains such as Banana Foster, EZ Bake Auto, Face Gas Auto, and Honey Bird, each bred for specific characteristics to meet the diverse needs of cultivators. By providing high-quality, non-GMO seeds, Trilogene Seeds caters to both commercial growers and personal cultivators seeking reliable and potent yields.

Through continuous innovation, rigorous scientific research, and strategic global partnerships, Trilogene Seeds has established itself as a leader in the cannabis genetics industry, dedicated to advancing cultivation practices and delivering superior products to the market.

Trilogene Seeds’ dedication to innovation is further exemplified by their investment in genomic research. The company is actively engaged in developing next-generation sequencing solutions aimed at accurately targeting genes of interest. This approach accelerates the breeding process, facilitating the rapid development of cannabis cultivars with desirable traits such as increased cannabinoid content, improved terpene profiles, and enhanced resistance to environmental stresses. By focusing on the functional parts of genes and their promoter regions, Trilogene Seeds is poised to make significant contributions to the field of cannabis genomics and breeding.